ABOUT GID BIO

Abby has spent the last five years of her career overseeing clinical studies at sites of varying sizes, including medical device startups and large universities. At GID BIO she is responsible for managing clinical research, from site review to initiation, to test the biotech company\’s cellular therapy in studies with FDA clearance. Prior to joining GID, Abby oversaw six pivotal device trials; three device post-approval studies; and three investigator-initiated studies from the clinical site level at Washington University School of Medicine in St. Louis and University of Colorado – Anschutz Medical School; and a sponsor-level trial at Obalon Therapeutics. Abby earned a master of science degree in nutrition from Saint Louis University.

Victoria began her tenure with GID BIO in 2015. She helped design a safety and feasibility trial and a pivotal trial to test GID’s stromal vascular fraction treatment for knee osteoarthritis. Her focus is on clinical trial design in support of therapeutic areas including osteoarthritis of the hand and shoulder; rheumatoid arthritis of the hand; diabetic ulcers; diabetic neuropathy; kidney fibrosis; and erectile dysfunction.   

 Victoria has over 24 years of experience in medical device research with participation in over 50 publications including peer-reviewed journals and societal presentations on devices. She began her career conducting simulator testing of hip and knee implants at Loma Linda University before devoting the last 15 years to developing and managing clinical trials at Zeiss, Covidien, Sonoma Orthopedics and GID BIO for ophthalmic diagnostics; respiratory and monitoring devices; orthopedic implants; and cellular biologics. 

Victoria earned a bachelor of science degree in physics from California State University – San Bernardino and a Ph.D. in bioengineering from Strathclyde University with an emphasis on orthopaedic tribology (study of wear, friction and lubrication).

Claire has been a scientist for 20 years including working as a forensic DNA analyst for Cellmark Forensics in the UK and US. For GID BIO she works as a clinical and training specialist, designing and implementing training courses, with a particular emphasis on e-learning, as well as hands-on training in the operating theatre. She also carries out research and development and IT projects. She has worked in field applications and training development for several molecular biology companies including Qiagen, Oxford Immunotec and Cepheid (Danaher) in the EU and EMEA. She also works on projects to expand Coronavirus (SARS-CoV-2) testing capacities, including the development of a 20-minute SARS-CoV-2 test. Claire earned an undergraduate degree in forensic science and law; a postgraduate certificate in research methods, and a Ph.D. in molecular biology.